The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Nature

Volumn 481, Issue 7380, 2012, Pages 157-163

  Zhang, Jinghui ^a   Ding, Li ^b   Holmfeldt, Linda ^a   Wu, Gang ^a   Heatley, Sue L ^a,n   Payne Turner, Debbie ^a   Easton, John ^a   Chen, Xiang ^a   Wang, Jianmin ^a   Rusch, Michael ^a   Lu, Charles ^b   Chen, Shann Ching ^a   Wei, Lei ^a   Collins Underwood, J Racquel ^a   Ma, Jing ^a   Roberts, Kathryn G ^a   Pounds, Stanley B ^a   Ulyanov, Anatoly ^a   Becksfort, Jared ^a   Gupta, Pankaj ^a   Huether, Robert ^a   Kriwacki, Richard W ^a   Parker, Matthew ^a   McGoldrick, Daniel J ^a   Zhao, David ^a   Alford, Daniel ^a   Espy, Stephen ^a   Bobba, Kiran Chand ^a   Song, Guangchun ^a   Pei, Deqing ^a   Cheng, Cheng ^a   Roberts, Stefan ^a   Barbato, Michael I ^a,q   Campana, Dario ^a,o   Coustan Smith, Elaine ^a,o   Shurtleff, Sheila A ^a   Raimondi, Susana C ^a   Kleppe, Maria ^c,p   Cools, Jan ^c   Shimano, Kristin A ^d   Hermiston, Michelle L ^d   Doulatov, Sergei ^e,f   Eppert, Kolja ^e,f   Laurenti, Elisa ^e,f   Notta, Faiyaz ^e,f   Dick, John E ^g   Basso, Giuseppe ^h   Hunger, Stephen P ^d   Loh, Mignon L ^d   Devidas, Meenakshi ⁱ   Wood, Brent ^j   Winter, Stuart ^k   Dunsmore, Kimberley P ^l   Fulton, Robert S ^b   Fulton, Lucinda L ^b   Hong, Xin ^b   Harris, Christopher C ^b   Dooling, David J ^b   Ochoa, Kerri ^b   Johnson, Kimberly J ^b   Obenauer, John C ^a   Evans, William E ^a   Pui, Ching Hon ^a   Naeve, Clayton W ^a   Ley, Timothy J ^b,m   Mardis, Elaine R ^b,m   Wilson, Richard K ^b,m   Downing, James R ^a   Mullighan, Charles G ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^j SEATTLE CHILDREN S HOSPITAL   (United States)

^k UNIVERSITY OF NEW MEXICO   (United States)

^l UNIVERSITY OF VIRGINIA   (United States)

^m USA   (United States)

ⁿ CENTRE FOR CANCER BIOLOGY   (Australia)

^o NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^p MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^q THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CD135 ANTIGEN; CYTOKINE RECEPTOR; DNM2 PROTEIN; E1A ASSOCIATED P300 PROTEIN; ECT2L PROTEIN; EMBRYONIC ECTODERM DEVELOPMENT PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R; INTERLEUKIN 7 RECEPTOR; JANUS KINASE 1; JANUS KINASE 3; K RAS PROTEIN; NRAS PROTEIN; PHF6 PROTEIN; RAS PROTEIN; REELIN; SETD2 PROTEIN; SH2B3 PROTEIN; SUZ12 PROTEIN; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

CANCER; CELL ORGANELLE; FREQUENCY ANALYSIS; GENE EXPRESSION; GENETIC ANALYSIS; GENOME; IDENTIFICATION METHOD; MUTATION; SIGNALING; TUMOR;

ARTICLE; BONE MARROW TUMOR; CANCER GENETICS; CELL MATURATION; CONTROLLED STUDY; GENE DISRUPTION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; PRE T LYMPHOCYTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGE OF ONSET; CHILD; DNA COPY NUMBER VARIATIONS; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HEMATOPOIESIS; HISTONES; HUMANS; JANUS KINASES; LEUKEMIA, MYELOID, ACUTE; MOLECULAR SEQUENCE DATA; MUTATION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, INTERLEUKIN-7; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STEM CELLS; T-LYMPHOCYTES; TRANSLOCATION, GENETIC;

EID: 84862907593     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10725     Document Type: Article

References (43)

1. Pui, C. H., Robison, L. L. & Look, A. T. Acute lymphoblastic leukaemia. Lancet 371, 1030-1043 (2008). (Pubitemid 351389536)
2. Coustan-Smith, E. et al. Early T-cell precursor leukaemia: a subtype of very highrisk acute lymphoblastic leukaemia. Lancet Oncol. 10, 147-156 (2009).
3. Rothenberg, E. V., Moore, J. E. & Yui, M. A. Launching the T-cell-lineage developmental programme. Nature Rev. Immunol. 8, 9-21 (2008).
4. Wada, H. et al. Adult T-cell progenitors retain myeloid potential. Nature 452, 768-772 (2008). (Pubitemid 351521082)
5. Wang, J. et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nature Methods 8, 652-654 (2011).
6. Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
7. Bohlander, S. K. ETV6: a versatile player in leukemogenesis. Semin. Cancer Biol. 15, 162-174 (2005).
8. Shurtleff, S. A. et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most commongenetic lesion in pediatric ALL and defines a subgroup ofpatients with an excellent prognosis. Leukemia 9, 1985-1989 (1995). (Pubitemid 26023779)
9. Barjesteh van Waalwijk van Doorn-Khosrovani, S. et al. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene 24, 4129-4137 (2005).
10. Yokota, S. et al. Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. Int. J. Hematol. 67, 379-387 (1998). (Pubitemid 28346351)
11. Kawamura, M. et al. Alterations of the p53, p21, p16, p15 and Ras genes in childhood T-cell acute lymphoblastic leukemia. Leuk. Res. 23, 115-126 (1999). (Pubitemid 29067555)
12. Flex, E. et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J. Exp. Med. 205, 751-758 (2008). (Pubitemid 351549874)
13. Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269-271 (2004). (Pubitemid 39336870)
14. Paietta, E. et al. Activating FLT3 mutations in CD117/KIT1 T-cell acute lymphoblastic leukemias. Blood 104, 558-560 (2004). (Pubitemid 38900041)
15. Van Vlierberghe, P. et al. Activating FLT3 mutations in CD41/CD8-pediatric T-cell acute lymphoblastic leukemias. Blood 106, 4414-4415 (2005). (Pubitemid 41775958)
16. Neumann, M. et al. High rate of FLT3 mutations in adult ETP-ALL. ASH Annu. Meet. Abstr. 116, 1031 (2010).
17. Van Vlierberghe, P. et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nature Genet. 42, 338-342 (2010).
18. Tosello, V. et al. WT1 mutations in T-ALL. Blood 114, 1038-1045 (2009).
19. Yamashita, Y. et al. Array-based genomic resequencing of human leukemia. Oncogene 29, 3723-3731 (2010).
20. Malinge, S. et al. Activatingmutations in humanacutemegakaryoblastic leukemia. Blood 112, 4220-4226 (2008).
21. Ziegler, S. F.& Liu, Y. J. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nature Immunol. 7, 709-714 (2006). (Pubitemid 43905869)
22. Russell, L. J. et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 114, 2688-2698 (2009).
23. Mullighan, C. G. et al. Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemia. Nature Genet. 41, 1243-1246 (2009).
24. Shochat, C. et al. Gain-of-function mutations in interleukin-7 receptor-a (IL7R) in childhood acute lymphoblastic leukemias. J. Exp. Med. 208, 901-908 (2011).
25. Kleppe, M., Mentens, N., Tousseyn, T., Wlodarska, I. & Cools, J. MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context. Haematologica 96, 779-783 (2011).
26. Hosoya, T.,Maillard, I.&Engel, J. D. Fromthe cradle to the grave: activities ofGATA-3 throughout T-cell development and differentiation. Immunol. Rev. 238, 110-125 (2010).
27. Zahirieh, A. et al. Functional analysis of a novel GATA3mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J. Clin. Endocrinol. Metab. 90, 2445-2450 (2005). (Pubitemid 40586298)
28. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. & Downing, J. R. AML1, the target ofmultiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (1996). (Pubitemid 26042836)
29. Downing, J. R. et al. An AML1/ETO fusion transcript is consistently detected by RNA-basedpolymerase chain reaction in acutemyelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 81, 2860-2865 (1993). (Pubitemid 23162101)
30. Dicker, F. et al. Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1andNRAS in 269 patients with MDS or secondary AML. Leukemia 24, 1528-1532 (2010).
31. Gaidzik, V. I. et al. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. J. Clin. Oncol. 29, 1364-1372 (2011).
32. Gelsi-Boyer, V. et al. Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer 8, 299 (2008).
33. Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343-349 (2011).
34. Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genet. 42, 181-185 (2010).
35. Durieux, A. C., Prudhon, B., Guicheney, P. & Bitoun, M. Dynamin 2 and human diseases. J. Mol. Med. 88, 339-350 (2010).
36. Hong, S. E. et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nature Genet. 26, 93-96 (2000).
37. Margolin, A. A. et al. Reverse engineering cellular networks. Nature Protocols 1, 662-671 (2006).
38. Novershtern, N. et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296-309 (2011).
39. Notta, F. et al. Isolation of single human hematopoietic stem cells capable of longterm multilineage engraftment. Science 333, 218-221 (2011).
40. Eppert, K. et al. Stemcell gene expression programs influence clinical outcome in human leukemia. Nature Med. 17, 1086-1093 (2011).
41. Mullighan, C. G. et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360, 470-480 (2009).
42. Gilliland, D. G. Molecular genetics of human leukemias: new insights into therapy. Semin. Hematol. 39, 6-11 (2002). (Pubitemid 35417143)
43. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639-1645 (2009).